(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.34%) $82.73
(6.55%) $2.05
(0.01%) $2 347.50
(-0.35%) $27.44
(4.11%) $960.00
(-0.21%) $0.933
(-0.41%) $10.98
(-0.51%) $0.796
(1.55%) $93.30
-1.73% INR 2 346.95
Live Chart Being Loaded With Signals
Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations...
Stats | |
---|---|
Dagens volum | 425 805 |
Gjennomsnittsvolum | 271 066 |
Markedsverdi | 194.65B |
EPS | INR0 ( 2024-02-01 ) |
Neste inntjeningsdato | ( INR6.03 ) 2024-05-08 |
Last Dividend | INR12.00 ( 2023-08-11 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 59.24 |
ATR14 | INR2.09 (0.09%) |
Volum Korrelasjon
Dr. Lal PathLabs Limited Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Dr. Lal PathLabs Limited Korrelasjon - Valuta/Råvare
Dr. Lal PathLabs Limited Økonomi
Annual | 2022 |
Omsetning: | INR20.17B |
Bruttogevinst: | INR15.70B (77.83 %) |
EPS: | INR28.82 |
FY | 2022 |
Omsetning: | INR20.17B |
Bruttogevinst: | INR15.70B (77.83 %) |
EPS: | INR28.82 |
FY | 2022 |
Omsetning: | INR20.87B |
Bruttogevinst: | INR13.00B (62.31 %) |
EPS: | INR41.70 |
FY | 2021 |
Omsetning: | INR15.81B |
Bruttogevinst: | INR11.84B (74.88 %) |
EPS: | INR35.33 |
Financial Reports:
No articles found.
Dr. Lal PathLabs Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR6.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR12.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR2.45 | 2016-07-20 |
Last Dividend | INR12.00 | 2023-08-11 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | INR77.95 | -- |
Avg. Dividend % Per Year | 0.37% | -- |
Score | 2.2 | -- |
Div. Sustainability Score | 2.87 | |
Div.Growth Potential Score | 3.08 | |
Div. Directional Score | 2.98 | -- |
Year | Amount | Yield |
---|---|---|
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR5.50 | 0.66% |
2019 | INR9.50 | 1.03% |
2020 | INR12.00 | 0.78% |
2021 | INR20.00 | 0.83% |
2022 | INR12.00 | 0.31% |
2023 | INR12.00 | 0.55% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GODFRYPHLP.NS | Dividend Junior | 2023-08-11 | Annually | 24 | 1.52% | |
AURIONPRO.NS | Dividend Junior | 2023-09-22 | Sporadic | 19 | 0.36% | |
TOUCHWOOD.NS | Dividend Junior | 2023-09-22 | Annually | 6 | 0.15% | |
PGIL.NS | Dividend Junior | 2023-09-01 | Annually | 17 | 1.08% | |
JINDALSAW.NS | Dividend Junior | 2023-06-13 | Annually | 22 | 1.62% | |
DEEPAKNTR.NS | Dividend Junior | 2023-07-27 | Annually | 14 | 0.25% | |
SKMEGGPROD.NS | Dividend Junior | 2023-08-30 | Sporadic | 21 | 0.95% | |
MGEL.NS | Dividend Junior | 2023-08-08 | Annually | 5 | 0.59% | |
HARSHA.NS | Dividend Junior | 2023-09-20 | Insufficient data to determine frequency | 2 | 0.09% | |
BDL.NS | Dividend Knight | 2023-09-20 | Semi-Annually | 7 | 1.17% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.152 | 1.500 | 6.96 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.190 | 1.500 | 9.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 15.29 | 1.000 | 5.45 | 5.45 | [3 - 30] |
operatingCashFlowPerShareTTM | 28.46 | 2.00 | 0.514 | 1.028 | [0 - 30] |
freeCashFlowPerShareTTM | 28.46 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.684 | 1.000 | 1.929 | 1.929 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.224 | 1.000 | 7.52 | 7.52 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.87 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 60.56 | 1.000 | 3.98 | 0 | [1 - 100] |
returnOnEquityTTM | 0.190 | 2.50 | 9.36 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 28.46 | 2.00 | 0.514 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.000 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 28.46 | 2.00 | 0.514 | 1.028 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.109 | 1.000 | 9.77 | 0 | [0.1 - 0.5] |
Total Score | 3.08 |
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.